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Background: An estimated 8.3%–16% of women experience vulvovaginal discomfort during 
their lifetime. Frequently these patients report provoked pain on contact or with attempted 
intercourse, commonly referred to as provoked vestibulodynia (PVD). Despite the burden of 
this condition, little is known about its potential etiologies including pelvic floor muscular dys-
function and mucosal components. This knowledge would be beneficial in developing targeted 
therapies including physical therapy.
Objective: To explore the relative contribution of mucosal versus muscle pain sensitivity on 
pain report from intercourse among women with PVD.
Design: In this proof of concept study, 54 women with PVD underwent a structured examina-
tion assessing mucosal and pelvic muscle sensitivity.
Methods: We examined three mucosal sites in the upper and lower vestibule. Patients were 
asked to rate their pain on cotton swab palpation of the mucosa using a 10-point visual analog 
scale. Muscle pain was assessed using transvaginal application of pressure on right and left 
puborectalis, and the perineal muscle complex. The Gracely pain scale (0–100) was used to 
assess the severity of pain with  intercourse, with women rating the lowest, average, and highest 
pain levels; a 100 rating the highest level of pain.
Results: The lower vestibule’s mucosa 5.81 (standard deviation =2.83) was significantly more 
sensitive than the upper vestibule 2.52 (standard deviation =2.6) (P,0.01) on exam. However, 
mucosal sensitivity was not associated with intercourse pain, while muscle sensitivity was 
moderately associated with both average and highest intensity of intercourse pain (r=-0.46, 
P=0.01 and r=-0.42, P=0.02), respectively.
Conclusion: This preliminary study suggests that mucosal measures alone may not sufficiently 
capture the spectrum of clinical pain report in women with PVD, which is consistent with the 
empirical success of physical therapy in this population.
Keywords: vulvodynia, provoked vestibulodynia, pain sensitivity, pelvic floor muscle pain, 
vulvar pain, pressure pain threshold, dyspareunia
Introduction
In a medical landscape filled with complex chronic pain disorders, none is as over-
looked as pain generated in the female reproductive system. An estimated 8.3%–16% 
of women experience vulvovaginal discomfort at some point in their lifetime.1,2 Among 
those who seek medical care, up to 60% will consult more than three physicians prior 
to receiving an appropriate diagnosis.1,2 The most common complaint among these 
women is provoked vulvar pain on contact, vaginal penetration or attempted intercourse, 
referred to as provoked vestibulodynia (PVD).1–4





The earliest documentation of this condition dates back 
to the 1800s.5 Current literature primarily refers to criteria 
developed in Friedrich’s study of 86 patients published in 
1987. Friedrich coined the term “vulvar vestibulitis syn-
drome” based on constellation of three signs and symptoms: 
1) severe pain on vestibular touch and entry dyspareunia, 
2) tenderness to pressure within the vestibule, and 3) physi-
cal findings limited to erythema without other obvious 
pathology.6,7 Despite considerable subsequent controversy 
surrounding nomenclature, the diagnosis by gynecologists of 
this condition continues to be based on Friedrich’s descrip-
tion of mucosal sensitivity. However, emerging literature 
suggests that mucosal sensitivity alone may not sufficiently 
capture the heterogeneity of patients with PVD.8 For example, 
in addition to mucosal sensitivity, a significant proportion 
of women with PVD experience pain in underlying pelvic 
musculature along with difficulty with volitional control of 
these muscles during clinical examination.9–11 However, the 
extent to which abnormalities in the anatomical form or func-
tion of pelvic musculature may contribute to the experience 
of pain in normal activities of women (ie, sexual activity), 
remains wholly unknown. Additionally, further elucida-
tion is needed of the potential interrelationship between 
how increased mucosal sensitivity may affect underlying 
musculature leading to compensatory contracture and 
hypertonicity which may further impact pain. Or conversely, 
underlying pelvic floor musculature dysfunction may primar-
ily and more directly lead to a neurogenic referred mucosal 
sensitivity. These theories have yet to be fully substantiated 
in the literature at the foundational level. The utility of such 
findings directly relate to the ability of clinicians to target 
therapies to either (or both) causes of vulvar pain, mucosal 
or muscle. Current physical therapy regimens for PVD have 
been somewhat successful,12,13 however, these therapeutic 
regimens are diverse including soft tissue manipulation, 
myofascial release, core strengthening exercises, dry nee-
dling, etc and could be better targeted to the type of pain.14,15 
Furthermore, the ability to better subtype pain contributors 
would be particularly helpful if the patient is in need of 
multimodal treatment inclusive of pharmacotherapy and 
behavioral health modalities.16,17 Therefore, the purpose of 
this study is to investigate the relationship between pain 
reported during sexual intercourse (dyspareunia) and the 
measurement of mucosal and muscle pain sensitivity among 
women with PVD during a structured clinical exam. In this 
study, we used a modified version of a previously developed 
clinical methodology to examine in detail the relationship 
between a patient’s self-report of pain during intercourse 
and mucosal and muscle pain sensitivity from a structured 
clinical research exam.18
Methods
This proof of concept pilot study was nested in a previously 
described study of women with PVD who in addition to 
completing a battery of questionnaires at two time points 
underwent a structured pelvic examination at the University 
of North Carolina (UNC).19 The UNC pelvic pain clinic’s 
referral pattern consists of 82% clinician referred female 
patients, with a median pain duration of 5 years, as well 
as a median number of three physicians seen prior to their 
initial UNC pelvic pain clinic visit. As a whole, our cohort 
of women consisted of the most intractable spectrum of 
women with PVD. The subjects presented with a wide spec-
trum of both mucosal and muscular pain sensitivity assessed 
via previously described standardized methodology.18 
Informed consent was obtained from all women who partici-
pated in this study. The Institutional Review Board at UNC, 
Chapel Hill, approved this study.
Of the previously described cohort of 137,19 54 women 
had a structured research exam on their first clinic visit and 
met the inclusion criteria described below. Following the 
conventional gynecological evaluation and diagnosis of PVD, 
participants underwent a more nuanced mucosal and pelvic 
muscle assessment consistent with clinical practice. The 
diagnosis of PVD was made based on the subjective report 
of pain during intercourse and tenderness to touch during a 
cotton swab exam; the diagnosis was rendered after excluding 
other identifiable etiologies. Patients with co-morbid urogeni-
tal pain conditions (eg, vaginismus, generalized vulvodynia, 
interstitial cystitis), dermatological conditions (eg, lichen 
sclerosis), chronic pelvic pain defined as non-menstrual 
daily pain localized to the pelvic region, and neuropathies 
(eg, pudendal neuralgia) were excluded.
The clinical exam and history were abstracted from the 
review of the medical records. Two independent reviewers20 
classified patients into clinically accepted subtypes of PVD: 
primary versus secondary. Women who developed PVD after 
a period of pain-free intercourse are considered secondary; 
those who endorse pain since coital debut or first tampon 
insertion are considered primary. The reviewers were masked 
to the participants’ questionnaire response. Agreement between 
the two reviewers was high. Of the 54 participants, 20 were 
classified as having primary PVD subtype. The remaining 34 
were either classified as having a secondary subtype (n=32), 
defined as developing pain after a pain-free interval, or could 
not be classified (n=2) due to missing or conflicting data.




Mucosa versus muscle pain sensitivity
Our structured mucosal sensitivity assessment consisted 
of a standardized approach to palpation and localization 
of individual mucosal sites on the vestibular surface area. 
The upper vestibular sites were examined first followed by 
examination of the lower vestibule. The six anatomical sites 
(three in the anterior and three in the posterior vestibule) 
were determined with reference to the conventional “clock 
face”. Using an imaginary clock, a total of 12 equidistant 
sites on the vestibule can be described circumferentially, 
with 12 and 6 positions corresponding to the anterior 
and posterior position on the midline (in dorsal lithotomy 
 position). Thus, sites 2, 10, and 12 are located in the upper 
vestibule and sites 5, 6, and 7 are located in the lower ves-
tibule (Figure 1).18 Furthermore, we used anatomical land-
marks to standardize the location of these vestibular sites 
among patients. Sites 2 and 10 correspond to mid-position on 
the vestibular mucosa located on an imaginary line through 
the urethral meatus and parallel to the horizontal plane. Site 
12 was located equidistant from the glans clitoris and the 
urethral meatus (measured vertically). The lower three sites 
were selected to reflect the mirror image of the upper ves-
tibular sites. Thus, 6 o’clock is the most posterior position 
on the vestibule and equidistant from 5 o’clock position on 
the right (subject’s left) and 7 o’clock position on the left 
(subject’s right).
With an inter-stimuli interval of 2 seconds, the upper and 
then lower vestibular sites were palpated in the following 
sequence: right, left, and midline. For example, examination 
of the upper vestibule consisted of palpating sites 10, 2, and 12 
sequentially. Using a cotton swab, we applied an approximate 
force of 1 Newton to each of the six vestibular sites using a 
method modified from our previous work.18 The algometer was 
not used in this protocol since data from our group suggest 
that the inter-rater reliability of cotton swab testing with and 
without the use of the algometer is Kappa =0.85 (unpublished 
data). To this end, each site was palpated for an approximate 
duration of 1 second or until mucosal blanching was observed. 
Based on our experience using a nuanced algometer,18 the 
above-mentioned methodology of mucosal assessment cor-
responded to 1–1.5 Newton per vestibular site.
Following each palpation, participants were instructed 
to verbally report the severity of pain (pain threshold) on 
a Likert scale of 0 (no pain) to 10 (worst pain imaginable). 
A numerical average of the three vestibular sites was used to 
calculate the corresponding upper and lower vestibule’s pres-
sure pain threshold (PPT) for the individual participants.
Pelvic muscle PPT measurements were obtained using 
a modified Jaeger’s technique, which consisted of digital 
calibration of the pressure with an algometer (Figure 2).21 
For these preliminary data only, the pelvic muscle PPT was 
assessed using the index finger calibrated to apply pressure at 
an increment of 500 g/s transvaginally, while carefully avoid-
ing the sensitive vestibular mucosa. This methodology was 
adapted and validated in the pelvic musculature18 from the 
literature in orofacial pain and fibromyalgia where pressures 
as low as 1,000 g (in orofacial region), and as high as 4,000 g 
are commonly applied for assessment of muscle pain.22,23
Based on our experience using a nuanced algometer,18 
the application of the above-mentioned methodology to 
the pelvic region leads to maximal stretch (ceiling effect) 
in pelvic musculature (specifically puborectalis) that var-
ies from 500 g to upward of 3,000 g. Three muscle groups 
were examined including the perineal muscle complex (this 
includes the convergence of the posterior fibers of the bilat-
eral bulbocavernosus muscles and the central midline of the 
transverse perineal muscle at 6 o’clock), the right puborec-
talis and the left puborectalis muscles (Figure 3).18 Pressure 
application points on the puborectalis were identified in the 
Figure 1 anatomical locations of the mucosal sites tested with a cotton swab.
Notes: Upper vestibule includes sites 2, 10, and 12. With 2 and 10 marking an 
imaginary line through the urethral meatus, and 12 is equidistant between. The 
lower vestibule sites include 5, 6, and 7 and are a mirror image of the upper 
vestibule. Reprinted from The Journal of Pain; 13(9); Zolnoun D, Bair e, essick g, 
gracely R, goyal V, Maixner W; Reliability and reproducibility of novel methodology 
for assessment of pressure pain sensitivity in pelvis; pages 910–920; copyright 2012, 
with permission from elsevier.18





following manner. The ventral surface of the right index 
finger facing the subject’s right pubic rami was carefully 
moved intravaginally. With a bent index finger (approximately 
30–60 degrees at the interphalangeal joints), the examiner 
palpated the mid-pubic rami. This bony landmark allows us 
to identify the mid-segment (belly) of puborectalis muscle. 
Once this location was confirmed, the examiner palpated 
the puborectalis muscle, immediately adjacent/behind the 
pubic rami (,0.5 cm). Subsequently, the examiner rotated 
the index finger downward (approximately 1–1.5 cm) parallel 
to the length of puborectalis. This was the point of pressure 
application for the assessment of PPT on the right and left 
puborectalis muscle. Following the assessment of the right 
side, the examiner rotated his/her right hand in order to pal-
pate the left puborectalis as described above.18
Participants were instructed to verbally signal at the first 
sensation of pain at which point the pressure application 
was terminated by the examiner. The pressure at which the 
examiner stopped the pressure application was defined as 
the PPT and recorded by the examiner. Each muscle site 
was examined three times with an inter-stimuli interval of 
15 seconds. Muscle PPT in each site was determined by 
the numerical average of these three measures. As with the 
mucosal data, the participant response data were analyzed 
based upon anatomic pain sensitivity as well as primary 
versus secondary pathology groupings.
Self-reported pain with intercourse was assessed by 
administering the Gracely pain scale, which asks women to 
rate the lowest, average, and maximal pain with intercourse 
on a scale of 0–100.24 Modified versions of this questionnaire 
are commonly used in assessing pain among patients with 
idiopathic pain disorders (eg, temporomandibular disorder 
and fibromyalgia).
Statistical analyses were performed using SAS 9.1 (SAS 
Institute Inc., Cary, NC, USA). Descriptive statistics (mean 
and standard deviation [SD] for continuous variables and 
frequency and percentages for bivariate variables) were cal-
culated. Student’s t-tests were used to compare continuous 
variables. We used a composite score consisting of the 
numerical average of the three vestibular sites in the lower 
and upper vestibule, respectively. We similarly averaged 
three threshold measures in order to obtain the site-specific 
muscle PPT. Pearson’s correlation was used for the purposes 
of describing the correlation between subjective report of 
pain with intercourse and mucosal and muscle pain sensitiv-
ity respectively; the correlations were similarly examined in 
subgroups of women with PVD. Statistical significance was 
set to (P,0.05) for all comparisons.
Results
Only 2% of eligible subjects declined participation in the 
study and were excluded in subgroup analysis. Our partici-
pants primarily consisted of college educated (80%), married 
(87%), white women (84%), aged 31 years (SD =7); 81% 
were nulliparous. The clinical subtype distribution of the 
study population included 37% classified as primary (n=20) 
and 60% classified as secondary (n=32), leaving two subjects 
classified as unknown.
On a pain scale of 0–10, the average mucosal assessment 
during cotton swab testing of the lower vestibule 5.81 (SD 
=2.83) demonstrated more sensitivity than the upper vestibule 
2.52 (SD =2.6) (P=0.01). Women presenting with primary 
and secondary PVD did not differ in severity of mucosal 
sensitivity on exam. However, self-reported severity of pain 
with intercourse showed some evidence of variation by sub-
groups of women with PVD, though these associations may 
be of marginal statistical significance. For instance, maximal 
intercourse-related pain was reported as 87.1 (SD =10.8) 
(0–100 scale) for women in the primary PVD subgroup and 
72.9 (SD =24.8) for women with secondary PVD (P=0.06).
Pain scores elicited in the more sensitive lower vestibule 
(0–10 scale) by the cotton swab examination demonstrated 
Figure 2 Finger sensor (A) and algometer (B) for calibration.
Notes: (A) adapted from The Journal of Pain; 13(9); Zolnoun D, Bair e, essick g, gracely R, goyal V, Maixner W; Reliability and reproducibility of novel methodology for 
assessment of pressure pain sensitivity in pelvis; pages 910–920; copyright 2012, with permission from elsevier.18
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a correlation with components of the modified Gracely pain 
scale (0–100) for the entire cohort of patients. However, while 
the average pain with intercourse was related to physical 
examination pain (r=0.38, P,0.01), neither the lowest pain 
nor maximal pain with intercourse demonstrated correlation 
with pain on physical examination (r=0.24 and 0.19, respec-
tively, P,0.10 for both). The above observation was true for 
both primary (r=0.27, P=0.29) and secondary subgroups 
(r=0.16, P=0.39).
Muscle pain threshold at each of the three tested sites 
varied from 500 to 2,000 g among women with PVD (n=30). 
In each site the three values used to define threshold were 
within 200–300 g of one another. The lowest PPT (highest 
tenderness) was observed in the perineal muscle complex 
with some women reporting pain at pressures as low as 500 
g. While puborectalis was similarly more likely to be tender 
in patients, few women (n=4) reported pain in the puborectalis 
muscles at pressures as high as those we observed in healthy 
controls (eg, 2,000 g).
We then used the PPT from the perineal complex to assess 
the relation between clinical pain report with sexual inter-
course and muscle tenderness. Women with greater muscle 
tenderness (lower PPT) reported more pain during intercourse. 
Average and highest intercourse-related pain was significantly 
correlated with lower muscle PPTs on examination (r=-0.46, 
P=0.01 and r=-0.42, P=0.02, respectively) (Figure 3). Women 
with primary PVD (n=13) had more muscle tenderness 905 g 
(SD =527) compared to women with secondary PVD n=17, 
1,276 g (SD =692), although this difference did not reach 
statistical significance (P=0.15) (Figure 4).
Discussion
This proof of concept study suggests differences in the 
relationship between intercourse pain (dyspareunia) report 
and mucosal and pelvic muscle sensitivity. The association 
between intercourse pain report and pelvic muscle pain was 
both stronger and statistically significant compared to that 
of the mucosal sensitivity; yet, the association of mucosa 
sensitivity was moderate overall. Furthermore, women with 
primary and secondary PVD did not differ on the spectrum 
of mucosal sensitivity.
As this is one of the first studies to examine clinical cor-
relates to mucosal and muscle sensitivity,8 our study has some 
limitations that should be considered when interpreting our 
findings. First, muscle assessment involved gradual pressure 
application with a termination point that could have been as 
high as 3,000 g and as low as 500 g. We used a continuous 
pressure application (at an approximate rate of 500/sec) 
because the range of pressure pain sensitivity in the pelvic 
muscles was unknown. As such, the reliability of measures 
are unlikely to be as high as that described for the conven-
tional approach where a set amount of pressure is applied 
by the examiner in all the participants. However, a single 
examiner (DZ) has conducted the exam at one point in time 
with high within-subject reproducibility (200–300 g differ-
ence between successive testing); this limitation is unlikely to 
significantly alter our findings. Second, we only investigated 
the relationship between 6 o’clock muscle and the clinical 
pain report due to a small sample size, the statistical con-
cern about multiple testing, and accepted norms. Third, we 
used a composite score for lower vestibule averaging pain 
intensity scores across sites 5, 6, and 7. Because of the small 
surface area of the vestibule, we anticipated that these sites 
were equally likely to contribute to experience of pain with 
intercourse. Detailed discussion of site-specific characteris-
tics of mucosal and muscle pain thresholds, along with the 
reliability and feasibility of contemporaneous assessment of 
pelvic muscle and mucosa is described elsewhere.18
In this study, muscle site 6 o’clock was noted to be 
the most sensitive and was therefore used in our analysis. 
This observation is nearly opposite of what we reported 
in a recently published study using a far more nuanced 
methodology.18 What is noteworthy is that these two studies 
were nearly contemporaneous. Specifically, the clinically 
relevant “bed side” assessment (in the present study) was 
intended to inform the design of the nuanced protocol. As 
we described in our methodology paper18 the gynecological 
sensory assessment could significantly alter exam findings. 
For example, in this study the examiner inadvertently used 
an inconsistent methodology for exams based on varying 
clinical scenarios. In women with primary PVD, the exam-
iner tried to minimize emotional aversion and discomfort 
by using the same index finger (right hand) to examine both 
Figure 3 anatomical location of muscle sites tested.
Notes: Reprinted from The Journal of Pain; 13(9); Zolnoun D, Bair e, essick g, 
gracely R, goyal V, Maixner W; Reliability and reproducibility of novel methodology 
for assessment of pressure pain sensitivity in pelvis; pages 910–920; copyright 2012, 
with permission from elsevier.18





right, left, and mid-perineal position. However, in most 
women with the secondary subtype, when deemed feasible, 
the examiner would change hands in order to ensure a more 
accurate pressure application. The end result was significant 
variability in muscle tenderness among subgroups, and incon-
sistent assessment of pelvic muscles, hence fewer women 
with data on pelvic muscle sensitivity. Nevertheless, it was 
in the course of this assessment that we made the important 
observation that the pattern of muscle and pelvic floor sen-
sitivity differed among women with primary and secondary 
vestibulodynia. Women with primary PVD subtype tended to 
be consistently more tender at 5 and 7 o’clock muscle position 
without much tenderness at 6 o’clock position;18 secondary 
subtypes varied from person-to-person though it commonly 
involved varying degrees of tenderness at 6 o’clock position. 
Because this study was conducted in a clinical setting with a 
higher number of women with secondary PVD, the 6 o’clock 
position emerged as being most sensitive.
We similarly observed challenges in assessing mucosal 
sensitivity among women with secondary PVD, many of 
whom were parous. In this subgroup, we could not con-
sistently identify a mucocutaneous junction (Hart’s line), 
and not uncommonly the vulvar mucosa indiscriminately 
was replaced by vaginal epithelium leading to a patchy 
perception. For example, a patient may have reported moder-
ate tenderness on the intact mucosa on the left side but no 
tenderness, or much lower levels of tenderness, on the right 
side that was replaced by the vaginal epithelium following 
childbirth. Thus, similar to muscle assessment, mucosal 
assessment proved to be more challenging than initially 
assumed. The limited association between clinical pain 
report and mucosal sensitivity may in part be explained by 
methodological challenges of assessing mucosa, particularly 
in parous women.
The limitation of the mucosal exam to reliably predict 
intercourse pain and differentiate subgroups of women with 
PVD raises fundamental questions regarding the adequacy 
of the mucosal sensitivity for classification purposes. 
Furthermore, the variation of mucosal sensitivity may theo-
retically result from not only intrinsic mucosal changes, but 
also from neuromuscular dysfunction and hypertonicity with 
referred neurogenic sensitivity. Reliability, reproducibility, 
and the validity of the mucosal assessment are further com-
pounded by yet uncharacterized anatomical variation.
Despite emerging data highlighting the complexity of pain 
among women with PVD, the diagnosis and classification of 
patients with PVD continues to be based on one-dimensional 
mucosal sensitivity. The findings of this study and, and perhaps 
more importantly, the challenges encountered in the course of 
this investigation, have enabled us to pilot and describe a more 
nuanced methodology for multidimensional assessment of 
pain in the pelvic region that reflects women’s report of pain. 
Further study on the effectiveness of physical therapies such 





































Figure 4 scatter plot of intercourse pain vs muscle pain detection.
Notes: The black line represents spearman’s correlation between average pain report with intercourse and muscle pain detection threshold, while the red line represents 
the correlation between highest pain with intercourse and muscle pain detection threshold.
Abbreviations: iRal, average pain with intercourse; iRhl, highest pain with intercourse.
Journal of Pain Research
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/journal-of-pain-research-journal
The Journal of Pain Research is an international, peer-reviewed, open 
access, online journal that welcomes laboratory and clinical findings 
in the fields of pain research and the prevention and management 
of pain. Original research, reviews, symposium reports, hypoth-
esis formation and commentaries are all considered for publication. 
The manuscript management system is completely online and includes 
a very quick and fair peer-review system, which is all easy to use. Visit 
http://www.dovepress.com/testimonials.php to read real quotes from 
published authors.





Mucosa versus muscle pain sensitivity
and core strengthening exercises which may address specific 
sources of muscle pain, and ultimately affecting patient out-
comes such as dyspareunia, should be investigated.
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